Conatus Pharmaceuticals, a biotechnology company focused on the development and commercialization of medicines to treat liver disease, has named Edward Smith III as senior vice president, regulatory affairs and quality assurance. “We are pleased to welcome Edward to the Conatus senior management team,” said Steven Mento, president and chief executive officer, Conatus. “His substantial experience includes U.S. and European regulatory filings across multiple therapeutic areas and drug/device ca...